Key result
Oral radioiodine in hyperthyroid cats leaves ~32% with abnormal echocardiograms, unlinked to T4 levels.
Why the study?
Does oral radioiodine administration improve echocardiographic abnormalities in spontaneously hyperthyroid cats?
Observational (n=91)
Does oral radioiodine administration improve echocardiographic abnormalities in spontaneously hyperthyroid cats?
Absolute Event Rate: 32% vs 37%
In hyperthyroid cats, pretreatment T4 levels do not predict echocardiographic abnormalities, and radioiodine treatment does not consistently resolve them.
No consistent echocardiographic resolution after radioiodine in cats; leaves open T4-independent mechanisms of persistent remodeling.
Ninety-one spontaneously hyperthyroid cats were studied by two-dimensional and M-mode echocardiography with in a week before and 2-3 months following oral radioiodine administration. A statistical search was made for a correlation between any of the linear echocardiographic variables (pre- or posttreatment) and the serum total thyroxine concentrations (pre- or posttreatment). No clinically useful relationships were found. Echocardiographic values were compared with a 95% confidence interval constructed from a previous multiinstitutional report on unsedated normal cats. Observed pretreatment abnormalities were primarily increases in interventricular septal and left ventricular wall thickness with reversion toward normal following treatment. The presence or absence of previous treatment with methimazole or concurrent treatment with cardiac-related drugs (beta-adrenergic blocker, calcium channel blocker, or angiotensin-converting enzyme inhibitor) had no statistically identifiable effect on the echocardiographic variables. About 37% of the cats had one or more echocardiographic variable(s) outside the calculated normal range before radioiodine treatment, but about 32% of the cats had one or more echocardiographic variable(s) outside that range after treatment (45% of these were normal before treatment). The conclusions are that pretreatment T-4 assessment was not useful in determining which cats may have potentially relevant echocardiographic abnormalities, that some echocardiographic abnormalities may emerge after treatment, and that less than 10% of the pre- or posttreatment abnormalities would be considered clinically relevant.
No takes yet. Share an insight, caveat, or question.
Weichselbaum et al. (2005) conducted an observational in Hyperthyroidism (n=91). Oral radioiodine administration vs. Pretreatment baseline was evaluated on Echocardiographic variables outside the calculated normal range. Oral radioiodine treatment in hyperthyroid cats resulted in 32% having abnormal echocardiographic variables post-treatment compared to 37% pre-treatment, with no correlation to T4 levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: